SEI Investments
CAPR icon

SEI Investments’s Capricor Therapeutics CAPR Stock Holding History

SEI Investments’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$541K Buy
17,805
+5,195
+41% +$138K ﹤0.01% 2625
2025
Q4 		$364K Buy
+12,610
New +$165K ﹤0.01% 2643
2017
Q3 		– Sell
-100
Closed -$1K – 3208
2017
Q2 		$1K Buy
+100
New +$1.83K ﹤0.01% 2915

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SEI Investments's CAPR Position: Q1 2026 in Review

SEI Investments increased its Capricor Therapeutics (CAPR) stake by 41% in Q1 2026, buying an estimated $138K and bringing the position to 17,805 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

SEI Investments first reported a position in CAPR in Q2 2017 and has held it in 3 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • SEI Investments held 17,805 shares of Capricor Therapeutics worth $541K as of Q1 2026.
  • SEI Investments bought 5,195 Capricor Therapeutics shares in Q1 2026, an estimated $138K.
  • Capricor Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2625 holding.
  • SEI Investments first reported a position in Capricor Therapeutics in Q2 2017 and has held it in 3 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.